{
    "info": {
        "nct_id": "NCT03260894",
        "official_title": "A Randomized, Open-Label, Phase 3 Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care (Sunitinib or Pazopanib) as First-Line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma (mRCC) (KEYNOTE-679/ECHO-302)",
        "inclusion_criteria": "* Histologic confirmation of locally advanced or metastatic RCC with a clear-cell component with or without sarcomatoid features.\n* Must not have received any prior systemic therapy for their mRCC.\n* Measurable disease based on RECIST v1.1.\n* Archival tumor tissue sample or newly obtained core or excisional biopsy of a tumor lesion as required.\n* Karnofsky performance status ≥ 70%.\n* Adequate organ function per protocol-defined criteria.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Use of protocol-defined prior/concomitant therapy.\n* Currently receiving or has received an investigational treatment as part of a study of an investigational agent or has used an investigational device within 4 weeks before randomization.\n* History of severe hypersensitivity reaction to study treatments or their excipients.\n* Active autoimmune disease that has required systemic treatment in past 2 years.\n* Known additional malignancy that has progressed or has required active treatment in the last 3 years.\n* Known active central nervous system metastases and/or carcinomatous meningitis.\n* History of (noninfectious) pneumonitis that required steroids or current pneumonitis.\n* History or presence of an abnormal electrocardiogram that, in the investigator's opinion, is clinically meaningful.\n* Significant cardiac event within 12 months before Cycle 1 Day 1.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Adequate organ function per protocol-defined criteria.",
            "criterions": [
                {
                    "exact_snippets": "Adequate organ function per protocol-defined criteria",
                    "criterion": "organ function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "per protocol-defined criteria",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Archival tumor tissue sample or newly obtained core or excisional biopsy of a tumor lesion as required.",
            "criterions": [
                {
                    "exact_snippets": "Archival tumor tissue sample or newly obtained core or excisional biopsy of a tumor lesion as required",
                    "criterion": "tumor tissue sample",
                    "requirements": [
                        {
                            "requirement_type": "availability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "source",
                            "expected_value": [
                                "archival",
                                "newly obtained core biopsy",
                                "newly obtained excisional biopsy"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Histologic confirmation of locally advanced or metastatic RCC with a clear-cell component with or without sarcomatoid features.",
            "criterions": [
                {
                    "exact_snippets": "Histologic confirmation",
                    "criterion": "histologic confirmation",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "locally advanced or metastatic RCC",
                    "criterion": "renal cell carcinoma (RCC) stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "locally advanced",
                                "metastatic"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "clear-cell component",
                    "criterion": "clear-cell component in RCC",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "with or without sarcomatoid features",
                    "criterion": "sarcomatoid features in RCC",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": "with or without"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Must not have received any prior systemic therapy for their mRCC.",
            "criterions": [
                {
                    "exact_snippets": "Must not have received any prior systemic therapy for their mRCC",
                    "criterion": "prior systemic therapy for mRCC",
                    "requirements": [
                        {
                            "requirement_type": "history of treatment",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Measurable disease based on RECIST v1.1.",
            "criterions": [
                {
                    "exact_snippets": "Measurable disease based on RECIST v1.1.",
                    "criterion": "disease",
                    "requirements": [
                        {
                            "requirement_type": "measurability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "assessment_criteria",
                            "expected_value": "RECIST v1.1"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Karnofsky performance status ≥ 70%.",
            "criterions": [
                {
                    "exact_snippets": "Karnofsky performance status ≥ 70%",
                    "criterion": "Karnofsky performance status",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 70,
                                "unit": "%"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Use of protocol-defined prior/concomitant therapy.",
            "criterions": [
                {
                    "exact_snippets": "Use of protocol-defined prior/concomitant therapy",
                    "criterion": "protocol-defined prior/concomitant therapy",
                    "requirements": [
                        {
                            "requirement_type": "use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of (noninfectious) pneumonitis that required steroids or current pneumonitis.",
            "criterions": [
                {
                    "exact_snippets": "History of (noninfectious) pneumonitis that required steroids",
                    "criterion": "history of noninfectious pneumonitis",
                    "requirements": [
                        {
                            "requirement_type": "treatment requirement",
                            "expected_value": "required steroids"
                        }
                    ]
                },
                {
                    "exact_snippets": "current pneumonitis",
                    "criterion": "current pneumonitis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History or presence of an abnormal electrocardiogram that, in the investigator's opinion, is clinically meaningful.",
            "criterions": [
                {
                    "exact_snippets": "History or presence of an abnormal electrocardiogram ... in the investigator's opinion, is clinically meaningful.",
                    "criterion": "abnormal electrocardiogram",
                    "requirements": [
                        {
                            "requirement_type": "history_or_presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "clinical_significance",
                            "expected_value": "clinically meaningful (in the investigator's opinion)"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active autoimmune disease that has required systemic treatment in past 2 years.",
            "criterions": [
                {
                    "exact_snippets": "Active autoimmune disease that has required systemic treatment in past 2 years.",
                    "criterion": "autoimmune disease",
                    "requirements": [
                        {
                            "requirement_type": "activity status",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "systemic treatment requirement",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "systemic treatment timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known active central nervous system metastases and/or carcinomatous meningitis.",
            "criterions": [
                {
                    "exact_snippets": "Known active central nervous system metastases",
                    "criterion": "central nervous system metastases",
                    "requirements": [
                        {
                            "requirement_type": "activity status",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "knowledge status",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "carcinomatous meningitis",
                    "criterion": "carcinomatous meningitis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of severe hypersensitivity reaction to study treatments or their excipients.",
            "criterions": [
                {
                    "exact_snippets": "History of severe hypersensitivity reaction to study treatments or their excipients",
                    "criterion": "severe hypersensitivity reaction",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "cause",
                            "expected_value": [
                                "study treatments",
                                "their excipients"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Currently receiving or has received an investigational treatment as part of a study of an investigational agent or has used an investigational device within 4 weeks before randomization.",
            "criterions": [
                {
                    "exact_snippets": "Currently receiving or has received an investigational treatment as part of a study of an investigational agent",
                    "criterion": "receipt of investigational treatment",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "has used an investigational device within 4 weeks before randomization",
                    "criterion": "use of investigational device",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 4,
                                "unit": "weeks before randomization"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known additional malignancy that has progressed or has required active treatment in the last 3 years.",
            "criterions": [
                {
                    "exact_snippets": "Known additional malignancy that has progressed",
                    "criterion": "additional malignancy",
                    "requirements": [
                        {
                            "requirement_type": "progression",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Known additional malignancy that ... has required active treatment in the last 3 years",
                    "criterion": "additional malignancy",
                    "requirements": [
                        {
                            "requirement_type": "active treatment requirement",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time frame",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Significant cardiac event within 12 months before Cycle 1 Day 1.",
            "criterions": [
                {
                    "exact_snippets": "Significant cardiac event within 12 months before Cycle 1 Day 1.",
                    "criterion": "significant cardiac event",
                    "requirements": [
                        {
                            "requirement_type": "occurrence_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "months before Cycle 1 Day 1"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}